Literature DB >> 9660765

The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription.

D Zhang1, A J Paley, G Childs.   

Abstract

The ZFM1 protein is both a transcriptional repressor and identical to the splicing factor SF1. ZFM1 was shown to interact with and repress transcription from the glycine, glutamine, serine, and threonine-rich transcription activation domain of the sea urchin transcription factor, stage-specific activator protein (SSAP). EWS, a human protein involved in cellular transformation in Ewing's sarcoma tumors, contains an NH2-terminal transcriptional activation domain (NTD) which resembles that of SSAP in both amino acid composition and the ability to drive transcription to levels higher than VP16 in most cell types. Here we report that ZFM1 also interacts with EWS in both two-hybrid assays and glutathione S-transferase pull-down experiments. The region on EWS which interacts with ZFM1 maps to 37 amino acids within its NTD. Overexpression of ZFM1 in HepG2 cells represses the transactivation of reporter gene expression driven by Gal4-EWS-NTD fusion protein and this repression correlates with ZFM1 binding to EWS. Furthermore, two proteins, TLS and hTAFII68, which have extensive homology to EWS, also interact with ZFM1. Recently, it was discovered that EWS/TLS/hTAFII68 are each present in distinct TFIID populations and EWS and hTAFII68 were also found to be associated with the RNA polymerase II holoenzyme. The association of ZFM1 with these proteins implies that one normal cellular function for ZFM1 may be to negatively modulate transcription of target genes coordinated by these cofactors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660765     DOI: 10.1074/jbc.273.29.18086

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1.

Authors:  A C Goldstrohm; T R Albrecht; C Suñé; M T Bedford; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  CAPER-α alternative splicing regulates the expression of vascular endothelial growth factor₁₆₅ in Ewing sarcoma cells.

Authors:  Gangxiong Huang; Zhichao Zhou; Hua Wang; Eugenie S Kleinerman
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

Review 3.  A subset of nuclear receptor coregulators act as coupling proteins during synthesis and maturation of RNA transcripts.

Authors:  Didier Auboeuf; Dennis H Dowhan; Martin Dutertre; Natalia Martin; Susan M Berget; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

4.  Gene activation by dissociation of an inhibitor from a transcriptional activation domain.

Authors:  Fenglei Jiang; Benjamin R Frey; Margery L Evans; Jordan C Friel; James E Hopper
Journal:  Mol Cell Biol       Date:  2009-08-03       Impact factor: 4.272

Review 5.  The TET family of proteins: functions and roles in disease.

Authors:  Adelene Y Tan; James L Manley
Journal:  J Mol Cell Biol       Date:  2009-09-24       Impact factor: 6.216

6.  TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins.

Authors:  L Yang; L J Embree; D D Hickstein
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

7.  SF1 Phosphorylation Enhances Specific Binding to U2AF65 and Reduces Binding to 3'-Splice-Site RNA.

Authors:  Rakesh Chatrikhi; Wenhua Wang; Ankit Gupta; Sarah Loerch; Alexandre Maucuer; Clara L Kielkopf
Journal:  Biophys J       Date:  2016-12-20       Impact factor: 4.033

8.  Major phosphorylation of SF1 on adjacent Ser-Pro motifs enhances interaction with U2AF65.

Authors:  Valérie Manceau; Matthew Swenson; Jean-Pierre Le Caer; André Sobel; Clara L Kielkopf; Alexandre Maucuer
Journal:  FEBS J       Date:  2006-02       Impact factor: 5.542

Review 9.  Soft tissue tumors associated with EWSR1 translocation.

Authors:  Salvatore Romeo; Angelo P Dei Tos
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

10.  Sporadic ALS has compartment-specific aberrant exon splicing and altered cell-matrix adhesion biology.

Authors:  Stuart J Rabin; Jae Mun Hugo Kim; Michael Baughn; Ryan T Libby; Young Joo Kim; Yuxin Fan; Randell T Libby; Albert La Spada; Brad Stone; John Ravits
Journal:  Hum Mol Genet       Date:  2009-10-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.